Alger Health Sciences FundAHSZX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$60.9M
Expense ratio
0.76%
1-year return
+23.1%
3 years, a year
+3.8%
5 years, a year
+2.2%
Holdings
60
What it aims to do.
Alger Health Sciences Fund seeks long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| TEVA Teva Pharmaceutical Industries Ltd | 4.58% |
| JOBY Impulse Dynamics Ireland | 4.57% |
| Forte Biosciences Inc | 4.28% |
| ARWR Arrowhead Pharmaceuticals Inc | 4.04% |
| WELL Welltower Inc | 3.23% |
| CAH Cardinal Health Inc | 3.22% |
| JNJ Johnson & Johnson | 2.99% |
| TWST Twist Bioscience Corp | 2.93% |
| MRK Merck & Company Inc | 2.89% |
| NKTR Nektar Therapeutics | 2.66% |
More on AHSZX.
- AHSZX overview
- AHSZX holdings
- AHSZX risk
- AHSZX costs
- AHSZX money in and out
- AHSZX share classes
- Compare AHSZX with other funds
Returns after fees, from the fund's SEC filings up to Apr 2026. Past returns are not a promise. Not financial advice.